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Tyrosinase is a type I membrane glycoprotein whose
activity is essential for melanin synthesis. Loss of
function mutations in tyrosinase is the cause of ocu-
locutaneous albinism 1. In the milder oculocuta-
neous albinism 1B form in which mutant proteins
retain residual activity, the severity of albinism
depends on the type of mutations expressed in the
melanocyte. In this study, we show that coexpression
of wild-type protein with temperature-sensitive tyro-
sinase mutants corrects the mutant conformation
defect in an activity-dependent manner. Exit from
the endoplasmic reticulum and complex carbohy-
drate processing in the Golgi was promoted when
temperature-sensitive tyrosinase mutants were ecto-
pically expressed in host melanocytes carrying wild-
type protein even at the nonpermissive temperature.
Incubation of transfected melanocytes with DOPA
(the cofactor and substrate for tyrosinase), or tyro-
sine (the substrate), further enhanced processing of
ectopic mutant proteins. The analysis of glycosyla-
tion-de®cient mutants revealed regions in tyrosinase
with high, low, and intermediate dependency on gly-
cans for maturation. We concluded that the presence
of tyrosinase activity enhances the maturation of
temperature-sensitive and glycosylation-de®cient
forms of tyrosinase. The results may explain the vari-
ation in pigmentation and the development of pig-
ment later in life in patients carrying different
mutant alleles of oculocutaneous albinism 1B. Key
words: albinism/endoplasmic reticulum/glycosylation and
temperature-sensitive mutants/protein folding/quality con-
trol. J Invest Dermatol 119:481±488, 2002
P
igmentation is a multistep process dependent on the
functional integrity of tyrosinase (TYR, monophenol
monooxygenase, EC 1.14.18.1), the rate-limiting activ-
ity in melanin synthesis. The enzyme catalyzes the
oxidation of monohydric and dihydric phenols (cate-
chols) to their corresponding quinone (Lerner et al, 1949).
Mutations in TYR are the cause of classic type I oculocutaneous
albinism (OCA1, OMIM 203100), an autosomal recessive genetic
disorder characterized by melanin de®ciency in melanocytes
resulting in complete absence of pigmentation in the skin, hair,
and eyes (King, 1998; Oetting and King, 1999). The mutations
identi®ed in TYR fall under two main functional groups: those that
cause complete loss of tyrosinase activity associated with severe
albinism (OCA1A), and those preserving residual activity (5%±10%
of wild-type protein) conferring a slightly less severe albino
phenotype (OCA1B) (reviewed in King, 1998; Oetting, 2000; see
also Albinism Database at URL http://www.cbc.umn.edu/tad).
Tyrosinase is a type I membrane glycoprotein consisting of 529
amino acids (including the N-terminal signal peptide of 18 amino
acids, accession number XM_027058) with a polypeptide back-
bone of »60 kDa. It is synthesized on endoplasmic reticulum (ER)
bound ribosomes and the cotranslational transfer of six or seven
N-linked oligosaccharide chains increases its molecular weight to
»70 kDa (Halaban et al, 1983, 1984, 1997; UÂ jvaÂri et al, 2001; see
Fig 7). Under normal conditions, complex sugar modi®cations in
the Golgi apparatus causes a further increase to »80 kDa, the size of
the mature wild-type isoform that is then transported to the
melanosome, the site of melanin synthesis (Halaban et al, 1983,
1997).
The exit of tyrosinase from the ER and its traf®c through the
secretory pathway is tightly regulated depending on proper folding
and sorting. Misfolded proteins, such as mutant TYR expressed in
albino melanocytes, are retained in the ER as the immature 70 kDa
glycoform bound to the ER chaperones calnexin and calreticulin
(Berson et al, 2000; Halaban et al, 2000; Toyofuku et al, 2001). In
addition, genetic analysis of inherited hypopigmentation disorders
demonstrated that mutations in other genes modify tyrosinase
stability and subcellular localization and/or function. For example,
individuals with OCA2 (OMIM 203200) suffer loss-of-function
mutations in the p-protein (Gardner et al, 1992; Rinchik et al,
1993; Lee et al, 1994; Oetting et al, 1998), which causes inactivation
of tyrosine within the mutant cells, disruption of melanosomal
structure, and misrouting of tyrosinase to other sites including the
cell membrane (Potterf et al, 1998; Orlow and Brilliant, 1999; Puri
et al, 2000). The albino phenotype of OCA2 is less severe than that
of OCA1A, but is similar to OCA1B in that some affected
individuals accumulate pigment later in life. The clinical manifest-
ations of OCA1B and OCA2 are often indistinguishable, indicating
that suppression of tyrosinase function can lead to a similar
phenotype (King, 1998; Passmore et al, 1999).
We have recently shown that exit of wild-type tyrosinase from
the ER to the Golgi is facilitated by its cofactor supplied in the
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medium or generated by its own enzymatic activity (Halaban et al,
2001). Failure to exit the ER is conferred not only on loss-of-
function mutant proteins, but also on wild-type tyrosinase with
diminished activity due to tumor-induced metabolic changes in its
immediate milieu, as in the case of melanoma cells (Halaban et al,
1997, 2001). In tyrosinase-positive amelanotic melanoma cells
inactivated tyrosinase accumulates in the ER and is then subse-
quently targeted to cytosolic proteasome for degradation (Halaban
et al, 1997, 2001). Tyrosinase maturation and pigmentation were
restored in melanoma cells by treatments with tyrosine, DOPA, or
alkalinization, conditions that induce enzymatic activity within
these cells (Halaban et al, 2001, 2002).
We therefore proposed that tyrosinase oxidation products
enhance proper folding of wild-type TYR and raised the possibility
that mutant OCA1B proteins with residual activity can also be
rescued by increasing the levels of tyrosinase reaction products.
This concept was explored by the analysis of a temperature-
sensitive variant and mutant proteins destabilized by the elimination
of speci®c glycans. The results show that processing of the
temperature-sensitive glycoforms was restored by coexpression
with wild-type tyrosinase in an activity-dependent manner.
MATERIALS AND METHODS
Cell cultures Immortalized mouse melanocytes established from a
black B10BR mouse (Tamura et al, 1987) termed wild-type, albino
melan c melanocytes from a Balb-c mouse (Bennett et al, 1989)
homozygous for the c-locus (Tyr) mutation C85S (Kwon et al, 1989;
Jackson and Bennett, 1990), termed albino, COS7 cells, and human
metastatic melanoma cells 501 mel were used for transfection. Normal
mouse melanocytes were cultured in Ham's F-10 medium supplemented
with glutamine (2 mM), penicillin±streptomycin (100 U per ml), 7%
horse serum (all from Gibco Life Technologies, Rockville, MD), and
12-O-tetradecanoyl phorbol-13-acetate (TPA, 85 nM) (Sigma-Aldrich,
St. Louis, MO) at 37°C in a 5% CO2 humidi®ed incubator. In some
experiments the Ham's F-10 medium, which contains 10 mM tyrosine,
was supplemented with tyrosine to a ®nal concentration of 200 mM or
400 mM, as indicated, and/or with freshly prepared DOPA (50 mM).
COS7 cells were grown in RPMI (Gibco) and the melanoma cells in
Ham's F-10 medium, both supplemented with 7% fetal bovine serum
(Gemini Bio-Products, Woodland, CA).
Construction of plasmids encoding wild-type and mutant
tyrosinase proteins The plasmid pcTYR carrying the human
tyrosinase gene was a gift from Dr. R. Spritz (Denver, CO). To generate
FLAG-tagged tyrosinase proteins, human tyrosinase encoding the wild-
type or mutant protein carrying the R402Q variant (Tripathi et al, 1991)
were excised from pCMV/TYR-GFP plasmids (Halaban et al, 2000) and
ligated into the HindIII/KpnI cloning sites of p3XFLAG-CMV-14
expression vector (Sigma). The QuikChange site-directed mutagenesis
kit from Stratagene (La Jolla, CA) was used to generate single-site
glycosylation deletion mutations, in which the consensus N-linked
glycosylation sites Asn-X-Thr/Ser in TYR-FLAG were eliminated or
modi®ed in the cDNA by changing threonine or serine to an alanine,
except for Thr373, which was changed to lysine to mimic the albino
mutation T373K as described previously (UÂ jvaÂri et al, 2001). The site at
Asn290 was also modi®ed by exchanging the proline at position 293 to
alanine (P293A) (UÂ jvaÂri et al, 2001). In all cases, DNA sequencing of the
tyrosinase gene veri®ed the inserted mutations. DOTAP-encapsulated
plasmid DNAs (20 mg each) were transfected into wild-type (B10BR) or
albino melan c mouse melanocytes carrying the loss-of-function
Tyr(C85S) mutation, following the manufacturer's instructions
(Boehringer Mannheim, Indianapolis, IN). Melanocytes were subjected
to selection in 0.4 mg per ml G418 starting 4±5 d after transfection.
Western blotting and precipitation Melanocytes were lyzed in
CHAPS buffer (2% CHAPS in 50 mM HEPES and 200 mM NaCl, pH
7.5) containing a cocktail of protease inhibitors (``Complete'' EDTA-
free, Boehringer Mannheim). Western blotting was performed with
whole cell lysates (40 mg protein per lane), FLAG-immunoprecipitated
products, or bead-bound wheat germ agglutinin (WGA, Sigma) af®nity
puri®ed glycoproteins.
Ectopic chimeric human tyrosinase was detected with anti-FLAG
monoclonal antibody (M2, Sigma) or T311 monoclonal antibody
recognizing human but not mouse tyrosinase (Chen et al, 1995), and
host mouse tyrosinase with goat M-19 polyclonal antibodies raised
against the C-terminal peptide of mouse tyrosinase (Santa Cruz
Biotechnology, CA). Antigen±antibody complexes were detected by
enhanced chemiluminescence (ECL, NEN Life Science Products,
Boston, MA) using the appropriate secondary antibody linked to horse-
radish peroxidase. Densities of tyrosinase bands on the X-ray ®lms were
estimated using an NIH image analyzer.
Tyrosinase activity Tyrosinase assays were performed with L-
tyrosine-[3,5-3H] (Perkin-Elmer Life Sciences) as a substrate (Pomerantz,
1976; Halaban and Lerner, 1977; Halaban et al, 1988). Brie¯y, TYR-
FLAG chimeric proteins were precipitated from 2% CHAPS cell lysates
(»250 mg per precipitate) with 2 mg of anti-FLAG M2 monoclonal
antibody and protein G-Sepharose beads (GammaBind G, Amersham
Pharmacia Biotech, Sweden) by rotating for 2 h in the cold. The bead-
bound immune complexes were then washed successively three times
with lysis buffer, and bead-bound immunoprecipitates (200 ml ®nal
volume), were incubated with 50 mM L-tyrosine, 1 mCi per assay L-
tyrosine-[3,5-3H], and 50 mM L-DOPA, for 30 min at 37°C. Reactions
were stopped with 200 ml solution of 10% activated charcoal in 0.1 M
citric acid (wt/vol), the charcoal slurries were passed through Dowex
columns (350 ml), and radioactivity of the eluate in scintillation ¯uid was
measured with a scintillation counter. Alternatively, whole cell lysates
(100 mg protein per assay) derived from TYR-FLAG transfected COS7
cells were used directly to assay tyrosinase activity. Parallel reactions with
extracts from mouse albino melanocytes devoid of tyrosinase activity and
nontransfected COS7 cells were used as negative controls (blanks), and
wild-type mouse melanocytes as a positive control. The assays were
carried out in duplicate or triplicate reactions and data are given as
average cpm with blanks subtracted. Standard deviation between
duplicates did not exceed 10% of total counts. All assays were repeated
once.
Carbohydrate cleavage Cell lysates (»250 mg protein) in 100 ml
CHAPS lysis buffer were incubated with 50 ml of bead-bound WGA for
2 h in the cold, under constant rotation. After washing twice with
CHAPS buffer and once with phosphate-buffered saline, bead-bound
glycoproteins were digested with endoglycosidase H (Endo H),
according to the manufacturer's instruction (Boehringer Mannheim).
Reaction products were subjected to Western blotting with anti-FLAG
or antityrosinase monoclonal antibodies.
RESULTS
TYR-FLAG chimera displays normal processing and
possesses tyrosinase activity The integrity of a TYR-FLAG
chimera was assessed by analyzing its sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) migration pattern,
carbohydrate modi®cation, enzymatic activity, and its ability to
induce the synthesis of melanin. Expression in wild-type mouse
melanocytes produced the 80±90 kDa chimeric protein that was
largely resistant to Endo H digestion (Fig 1A, lanes 1, 2). The small
decrease in the electrophoretic mobility of the mature protein after
Endo H digestion is similar to that observed in native human
tyrosinase (Halaban et al, 2001), and is probably due to digestion of
a portion of the seven glycans that escaped complex sugar
processing in the Golgi (UÂ jvaÂri et al, 2001).
In the heterologous cellular system COS7 cells, TYR-FLAG was
slightly smaller in size compared to that synthesized in wild-type
mouse melanocytes (Fig 1A, compare lanes 1±3), possibly due to
incomplete complex carbohydrate processing. In addition, a
portion of the protein was digested by Endo H to the
deglycosylated form (Fig 1A, lane 4, band marked S for Endo H
sensitive), indicative of tyrosinase with high mannose forms
characteristic of ER resident species (Halaban et al, 1997). These
results showed that the processing of tyrosinase in the heterologous
COS7 cellular system was not optimal.
In human melanoma cells (501 mel), a large portion of TYR-
FLAG was also sensitive to Endo H digestion (Fig 1A, lanes 5±8),
consistent with the previously characterized folding defect for
native tyrosinase in these cells (Halaban et al, 1997; 2001). The
same membrane was blotted successively with a monoclonal
antibody against FLAG (Fig 1A, lanes 5±6, a-FLAG) and then
against tyrosinase (Fig 1A, lanes 7±8, a-TYR). This showed that
the chimeric protein behaved similarly to the endogenous wild-
type human protein, and that the FLAG epitope encoding for 19
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amino acids caused an upward electrophoretic mobility shift of the
expected 2 kDa (Fig 1A, lanes 6, 8, marked S).
The accumulation of TYR-FLAG in COS7 cells after incuba-
tion in high tyrosine and DOPA (Fig 1B) indicated that the
chimeric protein responded to its substrates and cofactor in a
fashion similar to that of native human TYR in melanoma cells
(Halaban et al, 2001). Finally, TYR-FLAG possessed normal
function as evidenced by the presence of tyrosinase activity in
COS7 whole cell lysates and in anti-FLAG immunoprecipitated
material from transfected mouse melanocytes (Fig 1C), and by the
accumulation of melanin in transfected COS7 cells (not shown).
Taken together, these results con®rmed that the C-terminal FLAG
tag on human TYR did not impair TYR processing and activity
when expressed in the three different cell types.
DOPA/tyrosine-induced maturation of the natural variant
TYR-R402Q We explored the effect of DOPA/tyrosine on the
naturally existing temperature-sensitive TYR-R402Q variant that
in combination with an albino mutant can cause albinism (Tripathi
et al, 1991; Spritz, 1994; Halaban et al, 2000). The temperature
sensitivity of TYR-R402Q-FLAG chimeras was validated by
measuring tyrosinase activity in anti-FLAG immunoprecipitated
proteins derived from transfected mouse melanocytes grown at the
nonpermissive and permissive temperature (Fig 2A).
Enhanced maturation of TYR-R402Q-FLAG was observed in
response to DOPA (Fig 2B), or increased tyrosine concentration
(Fig 2C). Complex carbohydrate modi®cation was enhanced at the
permissive temperature (32°C) in the presence of DOPA (Fig 2B),
and at the nonpermissive temperature (37°C) with a high tyrosine
concentration (400 mM) when the mutant was expressed in wild-
type but not in albino melanocytes (Fig 2C). Figure 2(C) also
Figure 1. TYR-FLAG displays characteristics of native TYR
protein. (A) and (B) Western blots with anti-FLAG (A, lanes 1±6; B) or
anti-TYR monoclonal antibody (T311) showing nondigested (±) or
Endo H digested (+) TYR-FLAG expressed in wild-type mouse
melanocytes (NM), COS7, or human melanoma (501 mel). Endo H
digestions were performed with precipitated material using WGA bound
beads (A, lanes 1±4, and B) or antityrosinase (goat M-19, A, lanes 5±8).
At the end of Endo H treatment, proteins were separated in 8% (A, lanes
1±4, and B) or 6% (A, lanes 5±8) polyacrylamide gels. The bar and arrows
indicate Endo H resistant (R) and sensitive (S) tyrosinase proteins,
respectively. Molecular weight markers are designated in kDa. (C)
Tyrosinase activity in TYR-FLAG expressing cells. Assays were
performed with anti-FLAG immunoprecipitated material from mouse
melanocytes (NM), or COS7 whole cell lysates. Data are expressed as
mean duplicates of total cpm minus blanks (reactions devoid of any cell
extract). Tyrosinase activity in parallel assays using nontransfected cells
was as in blanks.
Figure 2. DOPA/tyrosine enhanced the stability and maturation
of TYR-R402Q albino mutant. (A) TYR-R402Q-FLAG enzymatic
activity expressed in wild-type mouse melanocytes. Transfected
melanocytes were kept at 37°C, or shifted to 32°C for 24 h (as
indicated). Chimeric proteins were precipitated from cell extracts
(250 mg protein per assay) with an anti-FLAG monoclonal antibody and
bead-bound materials were subjected to tyrosinase assay. Data are means
of duplicate assays expressed as total cpm. Standard deviation did not
exceed 10% of total counts. (B) Maturation of TYR-R402Q-FLAG
expressed in wild-type and albino melanocytes in response to downward
temperature shift and DOPA. Melanocytes were exposed to the
experimental conditions for 24 h, and equal amounts of protein (40 mg
per lane) were subjected to Western blotting with anti-FLAG
monoclonal antibody. Bars indicate mature (M) and immature (IM)
TYR proteins. (C) Stabilization and maturation of TYR-R402Q-FLAG
in response to tyrosine. Melanocytes (wild-type and albino) expressing
TYR-R402Q-FLAG were grown continuously in regular Ham's F-10
medium containing 10 mM tyrosine (0), or in Ham's F-10 medium
supplemented with 400 mM tyrosine for 2 or 4 d (as indicated). Equal
amounts of cell extracts (500 mg per assay) were subjected to bead-bound
WGA precipitation, followed by digestion without (±) or with (+) Endo
H. TYR-R402Q-FLAG was detected by Western blotting with anti-
FLAG monoclonal antibody. Bars indicate mature and immature TYR
species, and small arrow marks deglycosylated, Endo H digested TYR-
R402Q-FLAG (S). Bars on the right-hand side indicate 110 kDa and
77 kDa marker proteins.
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shows that tyrosine induced the accumulation of the immature
Endo-H-sensitive TYR-R402Q-FLAG regardless of the genetic
background of the host melanocytes. This accumulation is probably
due to increased stability and resistance to proteolytic degradation
(Halaban et al, 1997).
The inef®cient maturation of temperature-sensitive proteins in
albino versus wild-type melanocytes could be caused by the
interference in the folding or oligomerization generated by a
dominant misfolded and ER retained host mutant TyrC85S
(Halaban et al, 2000), rather than by the positive effect generated
from wild-type tyrosinase activity. We therefore assessed the
maturation of TYR-R402Q-FLAG expressed in COS7 cells,
which lack endogenous tyrosinase, in response to DOPA and
temperature shift. These results were compared with TYR-
R402Q-FLAG expressed in wild-type and albino melanocytes.
Western blot analyses with anti-FLAG monoclonal antibody
showed that processing in the albino background was similar to
that in COS7 cells (Fig 3). The ratio of mature to immature
R402Q-TYR-FLAG in these two cell lines, as indicated by the
densities of the respective bands assessed with an NIH image
analyzer, was similar and was smaller than FLAG-tagged R402Q-
TYR expressed in wild-type mouse melanocyte cells (Fig 3, M/I
ratios below bands). These results indicate that the presence of the
tyrosinase cofactor produced by the enzymatic activity of the host
tyrosinase may be the driving force behind the proper maturation.
Elimination of speci®c N-linked glycosylation sites hinders
processing of tyrosinase Glycans can be important for proper
folding of glycoproteins and elimination of a particular site can
confer temperature sensitivity for folding (Hebert et al, 1997;
reviewed in Helenius and Aebi, 2001). To assess the contribution
of each of the seven glycosylation sites to TYR conformation,
glycan-de®cient mutants were created. The Thr or Ser in each of
the human TYR N-glycosylation consensus sites was changed to
Ala, except for Thr 373, which was substituted with Lys to mimic
the common T373K natural OCA1 mutation as described
previously (UÂ jvaÂri et al, 2001). The wild-type and mutant
cDNAs were then ectopically expressed as FLAG-tagged proteins
in wild-type or albino mouse melanocytes.
Western blot analysis showed that elimination of each glycan
individually produced proteins that migrated by SDS-PAGE faster
than their wild-type counterpart (Fig 4). The immature ER form
displayed a 3 kDa size reduction consistent with the loss of the
expected mass of a single high mannose glycan (Fig 4, top panel,
bands marked IM for immature). Because six or seven glycans are
processed on TYR (UÂ jvaÂri et al, 2001), the resulting mutant
proteins displayed a doublet consisting of ®ve or six glycans, except
for the T292A mutant. This mutant consistently produced a protein
with six glycans due to elimination of the variable site whose
glycosylation is suppressed »50% of the time by an adjacent proline
(UÂ jvaÂri et al, 2001). Likewise, elimination of this adjacent proline,
Pro293, produced a protein that maintained seven glycans (Fig 4,
P293A). Complete digestion of the doublet protein from several
mutants by Endo H con®rmed that it is the ER immature form
(data not shown).
When expressed in wild-type mouse melanocytes, the seven
glycosylation mutants could be divided into three groups with
respect to their ability to mature into fully processed »90 kDa
protein that had received complex sugars in the Golgi (Fig 4, top
panel): (i) normally processed (S163A, T292A, and P293A); (ii)
partially processed (T88A, T113A, and T232A); and (iii)
unprocessed (S339A and T373K). When expressed in albino
melanocytes, however, the de®ciency in maturation was more
extensive (Fig 4, bottom). Wild-type TYR-FLAG and the chimeric
proteins carrying the T232A, T292A, and P293A substitutions
remained the most ef®ciently processed proteins, although in some
cases a larger portion persisted as the ER unprocessed form
compared to proteins expressed in wild-type melanocytes (Fig 4,
bottom panel, bands marked IM). The category of unprocessed
proteins extended to include T88A, T113A, and S163A TYR-
FLAG chimeric proteins. Only T232A, T292A, and P293A
matured to the same extent in the albino background as in wild-
Figure 3. Maturation of TYR-R402Q-FLAG is promoted by
endogenous tyrosinase activity and is not impeded by the albino
mutant. Mouse melanocytes (wild-type and albino) and COS7 cells
expressing TYR-R402Q-FLAG were incubated in medium
supplemented with 200 mM tyrosine, in the absence (±) and presence (+)
of DOPA (50 mM) at the nonpermissive (37°C) and permissive (32°C)
temperature overnight (16 h). Bead-bound WGA material precipitated
from equal amounts of cell extracts (250 mg) was treated (+) or not
treated (±) with Endo H. Reaction products were subjected to Western
blotting with anti-FLAG monoclonal antibody. Numbers under lanes
represent the band density ratio of mature to immature (M per I)
glycoforms as assessed by NIH image analyzer.
Figure 4. Elimination of speci®c glycans hinders processing to
different degrees in a cell-type-dependent manner. TYR-FLAG
(wild-type and substitution mutants at positions as indicated) were
expressed in wild-type and C85S albino mouse melanocytes. Anti-FLAG
Western blots were performed on WGA bound material (a-FLAG).
Host tyrosinase proteins are represented by Western blot of whole cell
lysates with antityrosinase (a-TYR, goat M-19). Tyrosinase proteins
with ®ve, six, and seven glycans are indicated on the left-hand side. M
and IM mark mature and immature protein bands, respectively.
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type melanocytes, suggesting that these mutations stabilized the
protein. Host tyrosinase proteins (Tyr) are represented by Western
blot of whole cell lysates with goat antityrosinase (a-TYR). The
wild-type and C85S albino mutant mouse tyrosinase each displayed
electrophoretic mobility characteristic of fully processed and Endo-
H-sensitive proteins as described previously (Halaban et al, 2000;
Toyofuku et al, 2001).
The various TYR-FLAG chimeric proteins also converted the
amelanotic albino melanocytes to pigmented cells with different
ef®ciencies. Although the level of pigmentation was dependent on
the fraction of cells expressing the ectopic genes, cells expressing
the T292A mutation were consistently darker than those expressing
the wild-type form.
Stabilization of glycosylation mutants at 32°C The
observations that the instability of glycan-de®cient mutants was
more prevalent when expressed in albino compared to wild-type
host melanocytes suggested that proper maturation of TYR can be
enhanced by the presence of wild-type TYR for a portion of the
mutants. We therefore examined maturation in response to
downward temperature shift from 37°C to 32°C. Time course
analysis showed that the total level of most of the chimeric proteins
increased within 4 h at 32°C when expressed in the wild-type
mouse melanocytes. This effect was most apparent for wild-type,
T88A, T113A TYR-FLAG chimeras (Fig 5A, top panel). In
contrast, there was no change in the level of FLAG-tagged TYR-
T292A, indicating again that elimination of this glycan produced a
protein with optimal stability. The reduction in temperature
resulted in a slight appearance in Golgi processing of S339A after 24
h that was not seen at the higher temperature, whereas no band
shift was observed for TYR-T373K-FLAG (Fig 5A, top panel,
S339A and T373K). A similar hierarchy of enhanced TYR
processing after downward temperature shift was observed when
the proteins were ectopically expressed in albino mutant
melanocytes (Fig 5A, bottom panels). The largest effect was seen
with T88A, T113A, and S163A, which changed from being
completely unprocessed at 37°C in albino cells, to being partially
processed at 32°C.
Successive immunoblotting of the same membranes (Fig 5A)
with goat polyclonal antibodies directed against mouse tyrosinase
(M-19) revealed that ectopic expression of human FLAG-TYR
albino mutant proteins did not affect the migration pattern or
stability of endogenous wild-type or C85S albino mutant mouse
tyrosinase (Fig 5B). In addition, as expected, the downward
temperature shift did not alter the characteristic levels of glycan
processing of each host protein. Wild-type and C85S albino mouse
tyrosinase appeared as fully processed 80 kDa and immature
70 kDa glycoforms, respectively, as reported before (Halaban et
al, 2000).
The increase in protein abundance and maturation was accom-
panied by a similar increase in tyrosinase activity and correlated
with the intrinsic level in each construct (Fig 5C). The highest
TYR activity was detected in TYR-T292A, whereas none was
detected in TYR-T373K FLAG chimeras regardless of tempera-
ture, con®rming previous results (Park et al, 1993). FLAG-tagged
Figure 5. Stabilization of TYR-FLAG by downward temperature shift. Mouse melanocytes (wild-type and albino C85S mutant) expressing
chimeric FLAG-tagged TYR proteins (wild-type or glycan de®cient, as indicated) were grown continuously at 37°C (0) or shifted to 32°C for the
indicated time interval. (A) Cell lysates from each transfectant were precipitated with WGA bound beads and subjected to Western blotting with
anti-FLAG monoclonal antibody. Equal amounts of protein were used with each transfectant. Protein ranged from 400 to 700 mg per assay. (B) Mouse
host proteins (wild-type and C85S mutant) in transfected cells. The membranes presented in (A) were successively blotted with goat antimouse
tyrosinase antibodies (M-19). Shown are two representative Western blots of S339A and T373K transfected melanocytes. The respective mouse
tyrosinase in the other blots appeared similar. (C) Tyrosinase activity in anti-FLAG immune precipitates. Cell extracts containing 200±250 mg protein
(equal amount for each transfectant) were subjected to precipitation with FLAG M2 monoclonal antibody, and bead-bound material was assayed for
tyrosinase for 30 min at 37°C. Data are averages of duplicate assays and are expressed as total cpm minus blanks. Variation between samples did not
exceed 10% of total counts.
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TYR-T88A displayed a dramatic increase in activity after 24 h
downward temperature shift, in agreement with induced processing
observed in immunoblots. Likewise, residual enzymatic activity was
measured in TYR-S339A after 2 d incubation at low temperature,
paralleling the low levels of maturation under similar conditions.
We therefore concluded that elimination of speci®c glycans
induced varying degrees of temperature sensitivity for maturation,
a defect that was eased in the presence of wild-type protein.
DOPA/tyrosine-induced maturation of temperature-
sensitive glycan-de®cient tyrosinase Because TYR-FLAG
proteins were destabilized particularly when expressed in albino
melanocytes that are null for TYR but normal for all other
melanocyte-speci®c proteins, we attempted to restore proper
maturation with tyrosine and DOPA. Toward this goal, the
transfected melanocytes were incubated with 400 mM tyrosine for 2
d, or with DOPA (50 mM) for 16 h. Western blot analysis of
chimeric proteins expressed in wild-type mouse melanocytes
showed that tyrosine and DOPA induced maturation and
accumulation of TYR-FLAG chimeric proteins in a fashion
similar to downward temperature shift (Fig 6A, B, top panel). As
before, the glycan-de®cient T88A and T113 TYR-FLAG were
most responsive, whereas the S339A and TYR-T373K mutants
were slightly or unaffected, respectively remaining largely
unprocessed regardless of the treatment. Tyrosine and DOPA also
stabilized wild-type TYR-FLAG, reminiscent of the response of
native tyrosinase in melanoma cells (Halaban et al, 2001), whereas
T292A TYR-FLAG remained unchanged, consistent with it
having already reached its optimal maturation level.
The role of tyrosinase activity in this process was further
con®rmed by incubating transfected albino melanocytes with
DOPA. In this genetic background, DOPA stabilized chimeric
proteins that possess residual levels of active mature protein at the
time of the assay (Fig 6B, bottom panel, compared to Figs 4, 5). For
example, maturation of T88A TYR-FLAG present as the 70 kDa
unprocessed glycoform with the lowest level of tyrosinase activity
(Fig 5) was not rescued by DOPA when expressed in the albino
background, whereas processing of the T113A and S163A with low
levels of mature glycoforms and endogenous activity was enhanced.
In contrast, the mutants S339A and T373K did not respond to
DOPA stimulation and remained unprocessed regardless of genetic
background. Altogether, the results showed that folding of
temperature-sensitive glycan-de®cient mutants can be enhanced
by the accumulation of tyrosinase reaction products at certain
threshold levels generated from self-activation or from coexpressed
wild-type protein.
DISCUSSION
We have previously shown that transport of wild-type tyrosinase
through the vesicular network, in particular from the ER to the
Golgi complex, is facilitated by its own cofactor and substrate
(Halaban et al, 2001). Agents that induced tyrosinase activity and
the subsequent production of DOPA also enhanced its traf®cking
from the ER to the Golgi, and possibly beyond to the
melanosomes. These observations are now extended to include
temperature-sensitive mutants of tyrosinase. The release of these
mutant proteins from the ER to the Golgi complex was dependent
on their intrinsic residual enzymatic activity and was further
enhanced by the activity of wild-type tyrosinase in the host
melanocyte. Coexpression of mutant proteins with wild-type
tyrosinase alleviated their conformational defect and enhanced
transit from the ER to the Golgi by an active process that was
dependent on the level of endogenous and ectopic tyrosinase
activity manipulated by tyrosine and DOPA. These observations
not only are signi®cant for understanding the myriad of levels of
pigmentation displayed by individuals carrying the autosomal
recessive OCA1B or OCA2 mutations, but also may provide a
mechanism to enhance pigmentation in individuals with residual
TYR activity.
The Golgi processing of the natural temperature sensitive variant
TYR-R402Q even at the nonpermissive temperature when
coexpressed as FLAG-tagged protein with wild-type tyrosinase
may explain the known phenotype of carriers of this mutation. The
R402Q substitution is found at high frequency in the normal
Caucasian population. Individuals that carry this allele in combin-
ation with null TYR, however, have reduced pigmentation during
Figure 6. Maturation of TYR-FLAG wild-type and mutant
proteins in response to tyrosine or DOPA. Western blotting with
anti-FLAG monoclonal antibody of proteins precipitated from cell
extracts with bead-bound WGA. (A) Mouse melanocytes (wild-type)
expressing wild-type or glycan-de®cient TYR-FLAG chimeric proteins
(as indicated at the top) were grown continuously in Ham's F-10
medium containing 10 mM tyrosine. Parallel cultures were either kept in
Ham's F-10 medium (L, for low tyrosine concentration), or were
subjected to Ham's F-10 medium supplemented with 400 mM tyrosine
(H, for high tyrosine concentration). Cultures were harvested 2 d later.
(B) Parallel cultures of mouse melanocytes (wild-type or albino, as
indicated), expressing wild-type or glycan-de®cient TYR-FLAG
chimeric proteins, were incubated without (±) or with (+) DOPA
(50 mM) for 1 d. Protein size markers are indicated in kDa.
Figure 7. Schematic representation of human TYR. The empty horizontal rectangle represents TYR 529 amino acid (aa) mature peptide
(accession number XM_027058). The hatched N-terminus box indicates the 18 amino acid signal peptide, the crossed area the epidermal-growth-
factor-like domain (E), the gray areas the Cu binding sites A and B, and the dark vertical bar the hydrophobic core transmembrane domain (TM). The
positions of the seven N-linked oligosaccharides are represented by the branched structures above the bar, with numbers indicating the position of Asn.
The inef®cient N-linked glycosylation at position 290 is denoted with an asterisk.
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embryogenesis, are born with ocular albinism, but develop pigment
later on in life (Oetting and King, 1999). The normal pigmentation
in homozygous R402Q carriers and the differences in melanin
synthesis before and after birth in heterozygotes with null mutations
could be explained by gradual accumulation of DOPA with time,
inducing stabilization and upregulating the levels of the protein
after birth.
Our analysis of glycan-de®cient mutants de®ned the role of each
of the seven N-linked glycosylation sites in tyrosinase maturation
(Fig 7). Two sites at position 337 and 371 were proven to be
indispensable for proper processing when eliminated. The Asn371-
X-T (the only N-linked glycosylation site known to be eliminated
by natural mutations) is the site of several substitutions identi®ed in
individuals with OCA1, which include the N371Y, N371T, and
T373K exchanges (reviewed in Oetting, 2000). The mutant
N371T and T373K proteins cause a severe OCA1 albino
phenotype (reviewed in Oetting, 2000). On the other hand,
TYR N371Y causes an OCA2 type of albinism, i.e., allowing some
formation of yellow pigment (Passmore et al, 1999). Analysis of an
additional mutation at this site, N371Q, produced by site directed
mutagenesis, also showed that the severity of misfolding is modi®ed
by the type of amino acid substitution, because the Asn to Gln
exchange allowed low levels of maturation (Xu et al, 2001). The
337 and 371 N-linked glycosylation sites in TYR ¯ank the copper
binding domain B (Fig 7), and a cluster of missense mutations in
this region are the cause of OCA1. It is possible that the two
glycans are needed to preserve the secondary structure that
maintains the two copper atoms in binding sites A and B at the
right distance to form a peroxide complex with molecular oxygen
(Gerdemann et al, 2002). Elimination of N-terminal glycans in
Tyrp1, a protein with high homology to TYR, at positions 304 or
385 also produced a protein that was retained in the ER (Xu et al,
2001). This suggests, by analogy to TYR, that these sites de®ne a
region in Tyrp1 critical for enzymatic activity, though the precise
nature of Tyrp1's activity is still disputed.
Elimination of glycans at positions 230 or 290 in TYR did not
reduce the stability of the protein below that of wild-type protein.
Moreover, elimination of the 290 site with the T292A alteration
was not only dispensable for folding but also conferred a more
stable conformation on tyrosinase. Interestingly, this N-linked
glycosylation consensus site is not present in mouse tyrosinase
(Kwon et al, 1988; Muller et al, 1988; Yamamoto et al, 1989), a
protein that is more ef®ciently processed than its human homolog
(Halaban et al, 2000). Furthermore, the proline at position 293
suppresses carbohydrate transfer to the N290 site producing the
doublet (TYR6/TYR7) observed for the ER glycoforms (UÂ jvaÂri
et al, 2001, and Fig 4). The TYR6 form is more prevalent in the
rapidly translating melanoma cells, however, for which TYR
maturation is compromised due to the presence of a hostile
maturation environment (UÂ jvaÂri et al, 2001; Halaban et al, 2002).
The remaining N-terminal N-linked glycosylation sites, N86,
N111, and N161, embedded in or next to the epidermal-growth-
factor-like motif of TYR (Oetting, 2000), produced temperature-
sensitive mutants for folding, particularly apparent when expressed
in the albino background. Whereas the FLAG-tagged proteins
TYR-T88A, TYR-T113A, and TYR-S163A remained as ER-
misfolded glycoforms when expressed in albino melanocytes grown
at 37°C, they were transported to the Golgi at this nonpermissive
temperature when expressed in wild-type melanocytes.
Interestingly, of the three, TYR-T88A-FLAG displayed the most
severe conformational defect. The T88A is adjacent to a critical
cysteine C89 and is located in a hot spot of OCA1 mutations,
suggesting again a critical region for TYR folding.
One should note that these ®ndings are in direct con¯ict with
results employing mouse tyrosinase, which possesses 85% sequence
identity with the human protein. Branza-Nichita et al (2000)
reported that the glycosylation sites at 111 and 161 in mouse
tyrosinase are not occupied, and that deletion of the 371 site (which
is associated with severe OCA1) results in the production of
tyrosinase with 63% of its relative enzymatic activity.
If tyrosinase is a homo-oligomer, the host cellular wild-type
tyrosinase may assist in the maturation of the transfected and tagged
proteins by pushing the oligomerization reaction towards product
formation regardless of its intrinsic catalytic activity. Alternatively,
the export of the temperature-sensitive mutants could be passively
enhanced by binding to the nascent wild-type tyrosinase in the ER
without obtaining the active conformation. If that were the case,
the transport to the Golgi should have been occurring regardless of
temperature, the levels of tyrosine, the presence of DOPA, or the
intrinsic residual enzymatic activity of the mutant proteins, because
wild-type mouse tyrosinase is continuously fully processed in these
cells.
Altogether, our results demonstrate that tyrosinase reaction
products enhance proper conformation not only of wild-type but
also of mutant tyrosinase proteins that possess residual enzymatic
activity. They imply that tyrosinase is destabilized when its own
reaction products are depleted. This concept is supported by our
previous observations that downregulation of tyrosinase activity in
tyrosinase-positive amelanotic melanoma cells is the cause for loss
of pigmentation.
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